Fanconi Anemia Complementation Group M C3469529
A genetic condition affecting DNA repair mechanisms. It can cause bone marrow failure, congenital abnormalities, and elevated cancer risk. Treatment focuses on supportive care and blood count monitoring.
Key facts at a glance
- ICD-10
- D61.03
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Easy bruising
(hematologic)Recurrent infections
(hematologic)Radial ray defects
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Allogeneic Hematopoietic Stem Cell Transplantation
Bone marrow transplant from a matched donor to replace defective hematopoietic stem cells. This is the definitive treatment for bone marrow failure in Fanconi anemia. Pre-transplant conditioning must be carefully adjusted due to heightened sensitivity to chemotherapy and radiation.
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Androgen Therapy
Synthetic androgens such as oxymetholone stimulate erythropoiesis and can improve blood counts. Response rates vary, and long-term use requires monitoring for liver toxicity and other adverse effects.
Additional treatment options
Surveillance for Hematologic Complications
Regular monitoring of blood counts, bone marrow examination, and screening for clonal evolution to myelodysplastic syndrome or acute leukemia. Early detection allows timely intervention.
monitoringBlood Product Transfusion Support
Red blood cell and platelet transfusions provide supportive care for anemia and thrombocytopenia. Transfusions should be judiciously used to minimize alloimmunization before potential transplant.
procedureNutritional Support and Micronutrient Supplementation
Comprehensive nutritional assessment and supplementation including folic acid, iron (if deficient), and other micronutrients to support hematopoiesis and overall health in patients with Fanconi anemia.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Fanconi Anemia Complementation Group M C3469529?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Fanconi Anemia Complementation Group M C3469529. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy